1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:

3.2.2 Macroeconomic factor analysis:

3.2.3 Developing base number:

3.2.4 Data Triangulation:

3.2.5 Country-level data:

4. Middle East and Africa Biologics Market - Key Market Dynamics

4.1 Market Drivers

4.1.1 Increasing Prevalence of Chronic Diseases

4.1.2 Preference for Outsourcing Manufacturing Operations

4.2 Market Restraints

4.2.1 High Cost of Biologics

4.3 Market Opportunities

4.3.1 Gene and Cell Therapy Advancements in Biologics

4.4 Future Trends

4.4.1 Strategic Initiatives by Companies

4.5 Impact of Drivers and Restraints:

5. Biologics Market - Middle East and Africa Analysis

5.1 Middle East and Africa Biologics Market Revenue (US$ Million), 2021-2031

5.2 Middle East and Africa Biologics Market Forecast Analysis

6. Middle East and Africa Biologics Market Analysis - by Product

6.1 Monoclonal Antibodies

6.1.1 Overview

6.1.2 Monoclonal Antibodies: Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

6.2 Vaccine

6.2.1 Overview

6.2.2 Vaccine: Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

6.3 Recombinant Hormones/Proteins

6.3.1 Overview

6.3.2 Recombinant Hormones/Proteins: Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

6.4 Cell and Gene Therapy

6.4.1 Overview

6.4.2 Cell and Gene Therapy: Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

6.5 Others

6.5.1 Overview

6.5.2 Others: Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

7. Middle East and Africa Biologics Market Analysis - by Application

7.1 Cancer

7.1.1 Overview

7.1.2 Cancer: Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

7.2 Infectious Diseases

7.2.1 Overview

7.2.2 Infectious Diseases: Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

7.3 Autoimmune Diseases

7.3.1 Overview

7.3.2 Autoimmune Diseases: Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

7.4 Others

7.4.1 Overview

7.4.2 Others: Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Middle East and Africa Biologics Market Analysis - by Source

8.1 Mammalian

8.1.1 Overview

8.1.2 Mammalian: Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

8.2 Microbial

8.2.1 Overview

8.2.2 Microbial: Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Middle East and Africa Biologics Market Analysis - by Manufacturing

9.1 Outsourced

9.1.1 Overview

9.1.2 Outsourced: Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

9.2 In-house

9.2.1 Overview

9.2.2 In-house: Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Middle East and Africa Biologics Market - Country Analysis

10.1 Middle East and Africa

10.1.1 Middle East and Africa Biologics Market - Revenue and Forecast Analysis - by Country

10.1.1.1 Middle East and Africa Biologics Market - Revenue and Forecast Analysis - by Country

10.1.1.2 South Africa: Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

10.1.1.2.1 South Africa: Middle East and Africa Biologics Market Share - by Product

10.1.1.2.2 South Africa: Middle East and Africa Biologics Market Share - by Application

10.1.1.2.3 South Africa: Middle East and Africa Biologics Market Share - by Source

10.1.1.2.4 South Africa: Middle East and Africa Biologics Market Share - by Manufacturing

10.1.1.3 Saudi Arabia: Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

10.1.1.3.1 Saudi Arabia: Middle East and Africa Biologics Market Share - by Product

10.1.1.3.2 Saudi Arabia: Middle East and Africa Biologics Market Share - by Application

10.1.1.3.3 Saudi Arabia: Middle East and Africa Biologics Market Share - by Source

10.1.1.3.4 Saudi Arabia: Middle East and Africa Biologics Market Share - by Manufacturing

10.1.1.4 United Arab Emirates: Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

10.1.1.4.1 United Arab Emirates: Middle East and Africa Biologics Market Share - by Product

10.1.1.4.2 United Arab Emirates: Middle East and Africa Biologics Market Share - by Application

10.1.1.4.3 United Arab Emirates: Middle East and Africa Biologics Market Share - by Source

10.1.1.4.4 United Arab Emirates: Middle East and Africa Biologics Market Share - by Manufacturing

10.1.1.5 Rest of Middle East and Africa: Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

10.1.1.5.1 Rest of Middle East and Africa: Middle East and Africa Biologics Market Share - by Product

10.1.1.5.2 Rest of Middle East and Africa: Middle East and Africa Biologics Market Share - by Application

10.1.1.5.3 Rest of Middle East and Africa: Middle East and Africa Biologics Market Share - by Source

10.1.1.5.4 Rest of Middle East and Africa: Middle East and Africa Biologics Market Share - by Manufacturing

11. Industry Landscape

11.1 Overview

11.2 Market Initiative

11.3 Partnerships and Collaborations

11.4 Other Developments

12. Company Profiles

12.1 AbbVie Inc

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Pfizer Inc

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Samsung Biologics Co Ltd

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 ADMA Biologics, Inc.

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 WuXi Biologics Inc

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Catalent Inc

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 AGC Biologics AS

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 AstraZeneca Plc

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Amgen Inc

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Nitto Avecia

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

12.11 Quality Assistance s.a.

12.11.1 Key Facts

12.11.2 Business Description

12.11.3 Products and Services

12.11.4 Financial Overview

12.11.5 SWOT Analysis

12.11.6 Key Developments

13. Appendix

13.1 About Us

List of Tables

Table 1. Middle East and Africa Biologics Market Segmentation

Table 2. Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Table 3. Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Product

Table 4. Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application

Table 5. Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Source

Table 6. Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Manufacturing

Table 7. Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country

Table 8. South Africa: Middle East and Africa Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product

Table 9. South Africa: Middle East and Africa Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application

Table 10. South Africa: Middle East and Africa Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source

Table 11. South Africa: Middle East and Africa Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Manufacturing

Table 12. Saudi Arabia: Middle East and Africa Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product

Table 13. Saudi Arabia: Middle East and Africa Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application

Table 14. Saudi Arabia: Middle East and Africa Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source

Table 15. Saudi Arabia: Middle East and Africa Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Manufacturing

Table 16. United Arab Emirates: Middle East and Africa Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product

Table 17. United Arab Emirates: Middle East and Africa Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application

Table 18. United Arab Emirates: Middle East and Africa Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source

Table 19. United Arab Emirates: Middle East and Africa Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Manufacturing

Table 20. Rest of Middle East and Africa: Middle East and Africa Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product

Table 21. Rest of Middle East and Africa: Middle East and Africa Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application

Table 22. Rest of Middle East and Africa: Middle East and Africa Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source

Table 23. Rest of Middle East and Africa: Middle East and Africa Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Manufacturing

List of Figures

Figure 1. Middle East and Africa Biologics Market Segmentation - Country

Figure 2. Middle East & Africa Biologics Market - Key Market Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Middle East and Africa Biologics Market Revenue (US$ Million), 2021-2031

Figure 5. Middle East and Africa Biologics Market Share (%) - by Product (2023 and 2031)

Figure 6. Monoclonal Antibodies: Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 7. Vaccine: Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 8. Recombinant Hormones/Proteins: Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 9. Cell and Gene Therapy: Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 10. Others: Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 11. Middle East and Africa Biologics Market Share (%) - by Application (2023 and 2031)

Figure 12. Cancer: Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 13. Infectious Diseases: Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 14. Autoimmune Diseases: Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 15. Others: Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 16. Middle East and Africa Biologics Market Share (%) - by Source (2023 and 2031)

Figure 17. Mammalian: Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 18. Microbial: Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 19. Middle East and Africa Biologics Market Share (%) - by Manufacturing (2023 and 2031)

Figure 20. Outsourced: Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 21. In-house: Middle East and Africa Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 22. Middle East and Africa Biologics Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 23. South Africa: Middle East and Africa Biologics Market - Revenue and Forecast, 2021- 2031 (US$ Million)

Figure 24. Saudi Arabia: Middle East and Africa Biologics Market - Revenue and Forecast, 2021- 2031 (US$ Million)

Figure 25. United Arab Emirates: Middle East and Africa Biologics Market - Revenue and Forecast, 2021- 2031 (US$ Million)

Figure 26. Rest of Middle East and Africa: Middle East and Africa Biologics Market - Revenue and Forecast, 2021- 2031 (US$ Million)